Key Points Earnings per share (non-GAAP) reached $1.91, surpassing estimates. GAAP revenue grew to $6.10 billion, ahead of analyst expectations by 24.3%, up 11.5% year over year. Full-year adjusted ...

Key Financial and Operational Developments Zimmer Biomet delivered GAAP revenue of $2.077 billion, beating analysts' expectations on a non-GAAP basis. Growth was especially strong in the S.E.T.

However, non-GAAP financials are still governed by the SEC. In fact, the SEC has taken action in the past against companies that it believes are being too aggressive with non-GAAP numbers.

(LLY) stock plunges as Phase 3 trial data for the company's oral weight loss drug orforglipron overshadow better than ...

Shares of Datadog (DDOG) rose about 11% premarket on Thursday after second quarter results beat estimates and the company ...

Sees revenue $960M, plus or minus $40M, consensus $946.07M. Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

While the company exceeded analyst expectations on several fronts, its Q3 outlook includes softer revenue and a slide back ...

Reports Q2 revenue $973M, consensus $932.42M. “We delivered revenue and adjusted EBITDA above the high end of our guidance, driven by strong year ...

Non-GAAP financial measures are used as a “complement,” like bread and butter, to supplement the earnings reported under GAAP. Because GAAP does not permit their inclusion in reported financial ...

IMGCAP (1)]The regulatory focus has sharpened recently on non-GAAP measures, by which I mean financial metrics, presented by companies outside the audited financial statements, that do not conform to ...